Genetic Engineering & Biotechnology News engagement report
@GENbio - 90K followers on X
Measured over 40 original posts from a 30-day window, last computed on August 28, 2026.
Engagement
A typical post picks up 14 interactions against 90K followers, an engagement rate of 0.015%. Measured over 40 original posts, its engagement rate beats 22% of 4,310 tracked accounts of a similar size. That is a reason to look at how the audience behaves - reply depth, saves, whether the followers are recent - rather than a conclusion about it on its own. Posts are seen about 1.5K times each, and 0.884% of those impressions turn into an interaction. That is about 1.70% of the follower count, which is the gap between an audience on paper and an audience in a timeline. Posting runs at about 1.3 post a day over the last 30 days, with activity on roughly 53% of days. Most posts go out around 15:00 UTC, and Thursday is the busiest day of the week. Of the 40 posts sampled, 15% carry an image or video and 100% link out. The account's strongest tracked post pulled 36 interactions, about 2.6x its own typical post. Recurring topics include #biotech, #nextgen, #bioprocessing.
Measured over 40 original posts from a 30-day window, last computed on August 28, 2026. Recurring tags: #biotech, #nextgen, #bioprocessing.
Compared with accounts its own size
Genetic Engineering & Biotechnology News's engagement rate beats 22% of the tracked X accounts closest to it in follower count (4,310 accounts, accounts of similar size (decile 4 of 10)). A percentile is spread evenly by construction, so 50 really is the middle of that group and 90 really is its top tenth.
On engagement per impression rather than per follower it beats 40% of the same group. When those two numbers disagree, the gap is about how far its posts travel rather than how people react to them.
Where this sits in the catalog
At 0.015%, Genetic Engineering & Biotechnology News sits above the 25th percentile of the 41,681 accounts in this comparison. That places it in the below the median band, which runs 0.013% to 0.083%.
Show the percentile table
| Percentile | Engagement rate |
|---|---|
| 10th percentile | 0.002% |
| 25th percentile | 0.013% |
| 50th percentile | 0.083% |
| 75th percentile | 0.447% |
| 90th percentile | 2.07% |
| 99th percentile | 143.4% |
This ruler is the whole measured catalog, not a size-matched group: it shows where the raw rate falls across every account we can measure, all of which are large. For a like-for-like comparison, read the size-band percentile above instead. See how the bands are built
Posting timing
This account posts most often around 15:00 UTC, and Thursday is its busiest day of the week. The bars below are the catalog-wide pattern, with this account's own busiest slot marked. They do not show how this account performs at each hour: we keep one aggregate per account, not one per hour, so that measurement does not exist in our data.
Show engagement by hour posted, utc as a table
| Hour (UTC) | Vs author median | Posts |
|---|---|---|
| 00:00 UTC | -1% | 58K |
| 01:00 UTC | -2% | 59K |
| 02:00 UTC | -3% | 58K |
| 03:00 UTC | -4% | 62K |
| 04:00 UTC | -6% | 50K |
| 05:00 UTC | -5% | 48K |
| 06:00 UTC | -5% | 56K |
| 07:00 UTC | -4% | 60K |
| 08:00 UTC | -4% | 70K |
| 09:00 UTC | -4% | 81K |
| 10:00 UTC | -3% | 83K |
| 11:00 UTC | -3% | 91K |
| 12:00 UTC | -2% | 100K |
| 13:00 UTC | -2% | 109K |
| 14:00 UTC | -3% | 112K |
| 15:00 UTC | -2% | 116K |
| 16:00 UTC | -4% | 113K |
| 17:00 UTC | -3% | 105K |
| 18:00 UTC | -2% | 98K |
| 19:00 UTC | -2% | 92K |
| 20:00 UTC | -1% | 86K |
| 21:00 UTC | -1% | 76K |
| 22:00 UTC | -2% | 66K |
| 23:00 UTC | -1% | 59K |
Show engagement by day of week as a table
| Day | Vs author median | Posts |
|---|---|---|
| Sunday | +5% | 255K |
| Monday | +1% | 328K |
| Tuesday | -2% | 353K |
| Wednesday | -4% | 317K |
| Thursday | -2% | 269K |
| Friday | -3% | 276K |
| Saturday | +3% | 249K |
Best tweets
- Aug 21, 20262.6x their median
Skull Immune Structures May Provide First Response Against Brain Cancer Uncovering localized immune niche changes view of neuroimmune interactions and opens new avenues for treating brain tumors and other neurological diseases @washumedicine #BrainCancer https://t.co/x7kSTwzpBr
- Aug 23, 20262.4x their median
Cell Therapy Company Aims to Pioneer Analytics Automation @BlueRockTx has developed a new automated system for the analytical auditing of cell therapies. It’s among the few systems specifically designed for this application. #bioprocessing #automation https://t.co/yePGr6b6zD
- Aug 24, 20262.2x their median
Lab-Grown Neocortex Models Mimic Early Brain Organization Scientists at @UCIrvine have developed a new approach that lets them engineer lab-grown human brain tissue with a defined regional identity. #omics #brain #organoids https://t.co/2wWLvFC4Or
- Aug 22, 20262.2x their median
Vector Production a Bottleneck for Gene Therapy Sector More effective purification materials would make viral vector production more efficient. Researchers can differentiate between full and empty capsids more effectively than current methods. @NCState https://t.co/ULbNcwiVAv
- Aug 15, 20262.2x their median
Allogeneic CAR T Company Prepares to Widen Access to Patients An allogeneic cell therapy company optimized their product using genome editing strategies and donor selection @CaribouBio #NextGEN #allogeneiccell #geneediting https://t.co/zREfi9B7y9
- Aug 23, 20262.1x their median
Cutting Costs in Serum-Free FGF2 Processing With Recycled Media Using L. lactis cells, fortified spent media, and continuous processing overcomes barriers to serum-free production. @ASTARsg #biomanufacturing #CellCulture https://t.co/K2kjfimfX5
- Aug 20, 20262.1x their median
Human Multi-Organ Chip Offers New Insight Into Cancer Metastasis A human multi-organ chip models how breast cancer spreads from blood vessels to bone and lung. @Columbia @kocuniversity @GVNlab #cancer #mestastasis https://t.co/cFO6DGt5EA
- Aug 16, 20261.9x their median
Software Can Solve CGT’s Sectors Traceability Challenges Software for the CGT sector can help developers keep track of both materials and data even as supply chains become more complex @Title21HS #NextGEN #artificialintelligence #celltherapy #genetherapy https://t.co/7d1stmkxTV
- Aug 18, 20261.9x their median
The State of Biotech is back. Alnylam's founding CEO. A Breakthrough Prize winner. Google Cloud's Life Sciences lead. The Biotech Hangout crew. GEN's outgoing EIC in his final interview. Free virtual summit. Sept 23. Register: https://t.co/HBPHYzW6rV #biotech #GoogleCloud https://t.co/lSrohVBUOu
- Aug 17, 20261.5x their median
CDMOs Expand and Build for Future Growth Executives from @FUJIFILMBiotech, @LonzaGroup, @MilliporeSigma, Samsung Biologics, and @thermofisher discuss their companies' recent service expansions and new facilities in interviews with GEN. #biomanufacturing https://t.co/RWcdjedZPf
Ranked by total interactions across everything we have tracked for this account, which is a longer history than the 30-day window the rates above use. The multiple compares each post to this account's own median.
Recurring topics
The most frequent hashtags in the sampled posts. They describe what this account writes about; they are not a performance signal, and the catalog-wide breakdown on the hub shows how little hashtag count moves.
Buy or sell X accounts - escrow-protected
PlayerSells is an escrow marketplace for X accounts. Every deal is protected, with no middleman risk.
Reading these numbers
A typical post picks up 14 interactions against 90K followers, an engagement rate of 0.015%. Measured over 40 original posts, its engagement rate beats 22% of 4,310 tracked accounts of a similar size. That is a reason to look at how the audience behaves - reply depth, saves, whether the followers are recent - rather than a conclusion about it on its own. Posts are seen about 1.5K times each, and 0.884% of those impressions turn into an interaction. That is about 1.70% of the follower count, which is the gap between an audience on paper and an audience in a timeline. Posting runs at about 1.3 post a day over the last 30 days, with activity on roughly 53% of days. Most posts go out around 15:00 UTC, and Thursday is the busiest day of the week. Of the 40 posts sampled, 15% carry an image or video and 100% link out. The account's strongest tracked post pulled 36 interactions, about 2.6x its own typical post. Recurring topics include #biotech, #nextgen, #bioprocessing.
- What is Genetic Engineering & Biotechnology News's engagement rate on X?
- Genetic Engineering & Biotechnology News (@GENbio) has an engagement rate of 0.015%, based on the median interactions across 40 original posts from the last 30 days against 89,595 followers. Replies, reposts and quote-posts of other people are excluded from that sample.
- Is that a good engagement rate?
- At 0.015%, Genetic Engineering & Biotechnology News sits above the 25th percentile of the 41,681 accounts in this comparison. Those comparison accounts are all large ones, because our scanning cadence is weighted towards big accounts, so this is a ranking among peers of similar scale rather than a ranking across X.
- Does @GENbio have real engagement?
- Its engagement rate beats 22% of the tracked X accounts closest to it in follower count (4,310 accounts), which puts it in the bottom quarter for its size group. Ranking inside a size band matters because engagement rate falls as accounts grow, so a raw rate would mostly re-measure the follower count. It is a starting point for a look at follower quality, not a verdict on it.
- When does @GENbio post?
- Most posts go out around 15:00 UTC, and Thursday is its busiest day, at roughly 1.33 posts per day across the measured window.